7 research outputs found

    Light harvesting by dye linked conducting polymers

    Get PDF

    Quantitative MALDI mass spectrometry imaging for exploring cutaneous drug delivery of tofacitinib in human skin

    Get PDF
    In skin penetration studies, HPLC-MS/MS analysis on extracts of heat-separated epidermis and dermis provides an estimate of the amount of drug penetrated. In this study, MALDI-MSI enabled qualitative skin distribution analysis of endogenous molecules and the drug molecule, tofacitinib and quantitative analysis of the amount of tofacitinib in the epidermis. The delivery of tofacitinib to the skin was investigated in a Franz diffusion cell using three different formulations (two oil-in-water creams, C1 and C2 and an aqueous gel). Further, in vitro release testing (IVRT) was performed and resulted in the fastest release of tofacitinib from the aqueous gel and the lowest from C2. In the ex vivo skin penetration and permeation study, C1 showed the largest skin retention of tofacitinib, whereas, lower retention and higher permeation were observed for the gel and C2. The quantitative MALDI-MSI analysis showed that the content of tofacitinib in the epidermis for the C1 treated samples was comparable to HPLC-MS/MS analysis, whereas, the samples treated with C2 and the aqueous gel were below LOQ. The study demonstrates that MALDI-MSI can be used for the quantitative determination of drug penetration in epidermis, as well as, to provide valuable information on qualitative skin distribution of tofacitinib

    Solubility Prediction of Different Forms of Pharmaceuticals in Single and Mixed Solvents Using Symmetric Electrolyte Nonrandom Two-Liquid Segment Activity Coefficient Model

    No full text
    An improved framework has been developed for solubility prediction of different forms of a medium-sized antibiotic (i.e., nonelectrolyte, electrolyte, and solvate) in single and mixed solvents using a symmetrically reformulated electrolyte nonrandom two-liquid segment activity coefficient (eNRTL-SAC) model. The methodology incorporates key features of the symmetric eNRTL-SAC model structure to reduce the number of parameters and uses a hybrid of global search algorithms for parameter estimation. Moreover, a design of experiments is included in the methodology to generate and use experimental data appropriately for model parameter regression and model validation. Because of the semipredictive nature of the symmetric eNRTL-SAC model, the segment parameter regression is a critical step for solubility prediction accuracy. A particle swarm optimization algorithm is incorporated to preregress conceptual segment parameters of solutes. The preregressed segment parameters were used as initial guesses for further segment parameter estimation. In this way, consistent segment parameters that reflect the characteristics of solutes in solution were estimated. The methodology application is demonstrated by predicting the solubility of fusidic acid, sodium fusidate, and fusidic acid acetone solvate in single and mixed solvents as well as at different temperature. The solubility predictions of fusidic acid, fusidic acid acetone solvate, and sodium fusidate in various single solvents show good agreement with experimental solubility with average squared relative errors of 0.055, 0.079, and 0.084 in logarithmic mole fraction scale, respectively. The model moreover predicts solubilities in binary solvent mixture and as a function of temperature in satisfactory agreement with experimental solubility

    Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients

    No full text
    <p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s13555-016-0125-6">https://link.springer.com/article/10.1007/s13555-016-0125-6</a></p><p></p> <p><br></p> <p><b>Provide enhanced content for this article</b></p> <p><br></p> <p>If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <a href="http://www.medengine.com/Redeem/”mailto:[email protected]”"><b>[email protected]</b></a>.</p> <p><br></p> <p>The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.</p> <p><br></p> <p>Other enhanced features include, but are not limited to:</p> <p><br></p> <p>• Slide decks</p> <p>• Videos and animations</p> <p>• Audio abstracts</p> <p>• Audio slides</p
    corecore